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Abstract
Background: Racial/ethnic disparities in the associations of body fatness with hormones and metabolic factors remain poorly un-
derstood. Therefore, we evaluated whether the associations of overall and central body fatness with circulating sex steroid hor-
mones and metabolic factors differ by race/ethnicity.
Methods: Data from 1,243 non-Hispanic white (NHW), non-Hispanic black (NHB) and Mexican-American (MA) adult men in the third
national health and nutrition examination survey (NHANES III) were analyzed. Waist circumference (central body fatness) was mea-
sured during the physical examination. Percent body fat (overall body fatness) was calculated from bioelectrical impedance. Asso-
ciations were estimated by using weighted linear regression models to adjust the two measures of body fatness for each other.
Results: Waist circumference, but not percent body fat was inversely associated with total testosterone and SHBG in all three
racial/ethnic groups after their mutual adjustment (all P < 0.0001). Percent body fat (P = 0.02), but not waist circumference was
positively associated with total estradiol in NHB men; no association was present in NHW and MA men (P-interaction = 0.04). Waist
circumference, but not body fat was strongly positively associated with fasting insulin (all P < 0.0001) and inversely associated with
HDL cholesterol (all P ≤ 0.003) in all three racial/ethnic groups. Both percent body fat and waist circumference were positively
associated with leptin (all P < 0.0001) in all three racial/ethnic groups.
Conclusions: There was no strong evidence in the associations of sex hormones and metabolic factors with body fatness in different
racial/ethnic groups. These findings should be further explored in prospective studies to determine their relevance in racial/ethnic
disparities of chronic diseases.
Keywords: Obesity, Hormones, Metabolic Factors, Race/Ethnicity, Men
1. Background
The prevalence of overweight and obesity, whether
measured by the overall amount or distribution of body
fat, has been increasing dramatically among American
men since 1980 (1); the prevalence is higher in some
racial/ethnic minority groups (1, 2). The racial/ethnic dif-
ferences in the prevalence of overweight and obesity are
thought, in part, to underlie racial/ethnic disparities in
risk of chronic diseases (3-5). Body fat may influence these
chronic diseases via alterations in sex steroid hormones,
insulin, and inflammatory mediators (6-8). We previously
observed in men in the US national health and nutrition
examination survey III (NHANES III) that percent body fat
or waist circumference (WC) was inversely associated with
serum total testosterone and sex hormone binding glob-
ulin (SHBG) concentrations and positively associated with
total estradiol after adjusting for race/ethnicity (9). Also in
NHANES III, we found that serum total testosterone con-
centration was highest in MA’s compared with NHB and
NHW men (10).
Copyright © 2017, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons
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2. Objectives
We evaluated whether the association of measures of
overall (body mass index (BMI) (11)) and central (waist cir-
cumference) body fatness with sex steroid hormones and
metabolic factors differs among NHW, NHB, and MA men.
3. Methods
3.1. Study Population
NHANES III used a multistage stratified and clustered
probability sampling, in which MA’s, NHB’s, and the el-
derly were oversampled to ensure adequate samples sizes,
and it is weighted to represent the total US civilian, non-
institutionalized population.
NHANES III had two phases (1988 - 1991 and 1991 - 1994)
from which independent, unbiased national estimates of
health and nutrition can be produced. Race was self-
reported. For Hispanic ethnicity, hand cards were used
to determine Mexican/Mexican-American ancestry. From
these race and ethnicity categories, we classified the par-
ticipants for this analysis as NHW, NHB, MA (12). For stud-
ies on sex steroid hormones, we selected men who partici-
pated in the morning session to reduce diurnal variation in
serum levels conditions (13). Men with a history of prostate
cancer were excluded to minimize the possible effects of
treatment on serum levels (n = 12) and other covariates (n
= 209) leaving a total of 1,243 men for the analyses.
Participants were interviewed and underwent an ex-
tensive physical examination during which a trained ex-
aminer measured height, weight, and waist circumfer-
ence. Cigarette smoking, alcohol consumption, and phys-
ical activity were assessed by questionnaire. Body mass in-
dex (BMI) was calculated as weight (kilograms) divided by
the square of height (meters). Percent body fat was cal-
culated from bioelectrical impedance analysis and weight
measurements using previously published formulas (14).
3.2. Measurement of Circulating Hormones and Metabolic Fac-
tors
Serum concentrations of total testosterone, total estra-
diol, and SHBG were previously measured in Dr. Nader
Rifai’s laboratory at Children’s hospital (Boston, MA) by
electrochemiluminescence immunoassays on a 2010 Elec-
sys autoanalyzer (Roche Diagnostics, Indianapolis, IN). The
lowest limits of detection were 0.02 ng/mL for testos-
terone, 5.00 pg/mL for estradiol and 3.00 nmol/L for SHBG;
no samples had concentrations below the limit of detec-
tion (LOD) for these analytes. Calculated free testosterone
and free estradiol concentrations were estimated from to-
tal testosterone and total estradiol, respectively, and SHBG,
and albumin concentrations using mass action equations
(15, 16). Detailed information on the laboratory meth-
ods used and quality measures for metabolic factors in
NHANES III have been reported previously (13, 17, 18).
3.3. Statistical Analyses
All statistical analyses were performed using SUDAAN
(19) as implemented in SAS v.9.1 (Cary, NC) software. Sam-
pling weights were applied in linear regression models to
take into account selection probabilities, over-sampling,
non-response, and differences between the sample and
the total US population. To normalize the hormone and
metabolic factor distributions (dependent variables), we
transformed the concentrations using the natural loga-
rithm. We ran multivariable linear regression models by
race/ethnicity with either percent body fat or waist cir-
cumference entered as a continuous variable (indepen-
dent variables) adjusting for age, smoking status, cotinine
concentration, alcohol consumption and physical activity.
To assess whether race/ethnicity modifies underlying rela-
tionships, we tested for interaction between race/ethnicity
and the two body fatness measures using the likelihood ra-
tio test.
We also estimated geometric mean hormone and
metabolic factor concentrations by race/ethnicity in three
joint categories of overall and central body fatness: 1)
obese-high (percent body fat ≥ 25%)/ high (waist circum-
ference≥ 102 cm), 2) obese on one measure only: -high (≥
25%)/normal (< 102 cm) or normal (< 25%)/high (≥ 102 cm),
and 3) non-obese - normal (< 25%)/normal (< 102 cm) (20,
21). We compared geometric mean concentrations among
the three categories of body fatness by race/ethnicity using
ANOVA. All P-values were from two-sided tests.
4. Results
4.1. Characteristics by Body Fatness Categories Within
Race/Ethnicity Groups
In Table 1 we describe the baseline characteristics of
the men by joint category of overall and central body fat-
ness (obese, obese on one measure only, non-obese) within
the three race/ethnicity groups. For each racial/ethnic
group, obese men were oldest and non-obese men were
the youngest. After age-adjustment, the prevalence of cur-
rent smoking and cotinine concentration indicative of ac-
tive smoking, tended to be lowest in the obese men and
highest in the non-obese men in each racial/ethnic group;
the prevalence of current smoking tended to be highest
in NHB men. The prevalence of a lack of physical activ-
ity was highest in the obese and lowest in the non-obese
categories in each racial/ethnic group, with the exception
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Lopez DS et al.
of NHB men. The prevalence of not drinking alcohol was
highest in obese men and lowest in non-obese men in each
racial/ethnic group; the prevalence of non-drinking was
the highest in NHB men in each joint category of overall
and central body fatness.
Racial/ethnic differences in the association of percent
body fat and waist circumference with sex steroid hor-
mones and metabolic factors
Table 2 presents the association of percent body fat and
waist circumference with natural logarithm transformed
sex steroid hormones and metabolic factors. Before their
simultaneous adjustment, both percent body fat and waist
circumference were inversely associated with total testos-
terone, calculated free testosterone, SHBG, HDL choles-
terol, and IGF-1; and positively associated with free estra-
diol, fasting insulin, total cholesterol, LDL cholesterol, and
leptin in each racial/ethnic group. Both percent body fat
and waist circumference were positively associated with
being above the limit of detection for C-reactive protein in
all three racial/ethnic groups.
To determine whether overall body fat or central body
fat was more strongly associated with the circulating fac-
tors by race/ethnicity, we simultaneously adjusted them
for the other. Percent body fat and waist circumfer-
ence both remained strongly positively associated only
with leptin; these associations were similar in all three
racial/ethnic groups. Only waist circumference remained
clearly inversely associated with total testosterone, SHBG,
and HDL cholesterol, and positively associated with free
estradiol and fasting insulin in each racial/ethnic group.
Only percent body fat remained positively associated with
total and free estradiol primarily in NHB men. These asso-
ciations are summarized in Table 3.
Geometric mean concentrations of sex steroid hor-
mone and metabolic factors by joint categories of overall
and central body fatness within racial/ethnic groups are
presented in an Online Supplement (Appendices 1 and 2 in
Supplementary File).
No significant pattern was observed for total-, free-
testosterone, SHBG, C-reactive protein > LOD, total choles-
terol, LDL cholesterol, HDL and leptin concentrations. In
Appendix 1 mean total and free estradiol concentrations
appeared to be highest in the obese category and lowest in
the non-obese category among NHW and among NHB men,
but total and free estradiol levels were similar in the obese
and non-obese categories among MA men (P-interaction =
0.002). In Appendix 2, IGFBP-3 was lowest in the obese and
obese by one measure categories than in the non-obese
category especially for NHW and MA men (P-interaction =
0.005).
5. Discussion
We examined whether the associations of overall
and central body fatness with sex steroid hormones and
metabolic factors differ by race/ethnicity. In general, waist
circumference, a measure of visceral adiposity, appeared
to be more consistently associated with these circulating
factors than percent body fat in each racial/ethnic group
when we simultaneously adjusted for percent body fat and
waist circumference to determine their independent asso-
ciations. We did identify a few exceptions, including a pos-
itive association between percent body fat, but not waist
circumference, and free estradiol in NHB men only. Al-
though there were no strong associations, the significance
of this work was the opportunity to investigate and iden-
tify some signicant interactions between race/ethnicity
and body fatness and their associations with hormones
and metabolic factors.
Racial/ethnic differences in the association between
body fatness and circulating hormones and metabolic fac-
tors have been previously investigated by using a single
body fatness measure (BMI, percent body fat, or waist cir-
cumference) (22-26). However, we chose to use percent
body fat in this analysis because the correlation between
BMI and the amount of body fat differs by race/ethnicity
(11).
Our findings are consistent with a previous study con-
ducted by Kupelian et al. showing an inverse association
between waist circumference and total and calculated free
testosterone and SHBG among NHW, NHB and Hispanic
men in a population-based epidemiologic survey (27). Two
small studies focused only on SHBG levels, and found an in-
verse association with waist-to-hip ratio among racial and
ethnic groups (28, 29). We and other colleagues have pre-
viously reported racial/ethnic differences in total testos-
terone, total estradiol and SHBG levels (10, 30), and in
a subsequent study we found independent associations
between sex steroid hormones and percent body fat (9,
31). Due to a paucity of studies investigating the role of
joint categories of overall and central body fatness on sex
steroid hormones by race and ethnicity, we cannot make
direct comparisons of our findings with other studies.
Our findings investigating the interplay between waist
circumference, percent body fat, and metabolic factors are
also consistent with previous studies (27, 32-37). Most of
these previous studies were conducted using BMI with sim-
ilar findings among different racial and ethnic groups (33,
34, 38-43). We found higher insulin concentrations in men
who were obese, and lowest in non-obese, among NHWs
and MAs, but unexpectedly insulin concentrations did not
differ across body fatness categories in NHBs.
Why the association of obesity with some sex steroid
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Table 1. Age-Adjusted Characteristics of 1,243 Men by Joint Categories of Overall and Central Body Fatness, NHANES III (Phase I), 1988 - 1991a , b
Variables Obese by Both Measures Obese by One Measure Only Non-Obese by Both Measures
HPBF (≥ 25%) and HWC (≥ 102 cm) HPBF (≥ 25%) and NWC (< 102 cm) OR NPBF (< 25%) and HWC (≥ 102 cm) NPBF (< 25%) and NWC (< 102 cm)
NHW NHB MA NHW NHB MA NHW NHB MA
No. participants 174 61 83 167 102 142 262 148 104
Age, y 50.1 (1.7) 42.1 (2.4) 43.6 (2.0) 43.4 (1.4) 41.8 (1.7) 34.9 (0.8) 38.3 (0.9) 37.6 (1.6) 33.3 (1.4)
BMI, kg/m2 32.5 (0.6) 35.1 (1.0) 32.0 (0.5) 26.3 (0.1) 26.4 (0.4) 26.0 (0.2) 23.4 (0.2) 23.1 (0.2) 23.5 (0.5)
Percent body fat, % 30.8 (0.3) 32.6 (0.7) 31.8 (0.6) 27.3 (0.3) 28.7 (0.5) 28.6 (0.2) 20.4 (0.2) 20.7 (0.4) 21.4 (0.4)
Waist, cm 112.2 (1.2) 113.9 (1.7) 109.0 (1.3) 95.7 (0.4) 92.0 (0.9) 92.5 (0.5) 86.7 (0.4) 82.1 (0.6) 85.6 (1.1)
Weight, lbs 228.3 (5.2) 244.6 (7.1) 205.4 (3.4) 181.7 (1.3) 179.2 (3.3) 161.3 (2.2) 160.6 (1.4) 157.0 (1.7) 150.6 (3.5)
Height, in 70.3 (0.3) 70.0 (0.2) 67.3 (0.4) 69.7 (0.2) 69.1 (0.3) 66.1 (0.3) 69.5 (0.2) 69.2 (0.3) 67.3 (0.4)
Cigarette smoking status
Never 29.6 43.5 36.8 33.6 41.8 46.2 35.8 32.6 45.5
Former 41.7 22.5 40.7 35.3 26.3 28.2 30.1 18.9 17.8
Current 28.7 34.0 22.5 31.1 31.9 25.6 34.1 48.5 36.7
Serum cotinine level (tobacco
smoke exposure), ng/mL
< 0.35 (none) 32.7 24.4 50.9 34.5 29.6 57.5 36.7 24.0 43.6
0.35 - 9.99 (passive) 31.5 35.7 26.1 24.0 28.6 20.6 24.3 26.4 18.8
≥ 10 (active) 35.8 39.9 23.0 41.5 41.8 21.9 39.0 49.6 37.6
Moderate and vigorous physical
activity, times/w
0 11.2 8.6 29.2 7.0 4.9 25.8 4.5 9.5 17.3
1 - 2 35.3 30.2 36.6 25.6 24.8 34.6 23.9 20.7 32.8
3 - 7 25.8 25.5 19.6 29.5 39.1 18.5 25.7 20.6 21.7
> 7 27.7 35.7 14.6 37.9 31.2 21.1 45.9 49.2 28.2
Alcohol consumption,
drinks/month
0 36.7 45.7 37.3 29.1 42.3 32.2 26.9 33.0 21.2
1 - 30 46.2 39.3 53.4 51.5 46.8 48.6 55.8 47.4 60.4
> 30 17.1 15.0 9.3 19.4 10.9 19.2 17.3 19.6 18.4
Abbreviations: HPBF, high percent body fat; HWC, high waist circumference; NPBF, normal percent body fat; NWC, normal waist circumference.
a Adjusted for age in years (continuous).
b Values are expressed as No. (%) or %.
hormones and metabolic factors differed by race/ethnicity
even after taking into account residual differences in the
amount of overall and central obesity is unclear. One possi-
bility is that despite similar BMI, percent body fat, waist cir-
cumference, racial/ethnic differences in visceral and sub-
cutaneous adipose tissue may exist (44). Indeed, a large
prospective study showed differences between white and
black men in visceral and subcutaneous adipose tissue as
measured by computed tomography after adjusting with
percent body fat, BMI, waist circumference, or WHR (45).
These findings have important implications because vis-
ceral adipose tissue is reported to be more metabolically
active than other adipose tissue sites (46) and possibly con-
tribute to other metabolic abnormalities associated with
weight gain (6, 47, 48).
Our study has a number of strengths. NHANES III is
a cross-sectional study representative of the civilian non-
institutionalized US population, which aids in the gener-
alizability of these results. Despites these strengths, the
current study has some possible limitations. First, we re-
lied on a single time point measurement of sex steroid hor-
mones and metabolic factors. In addition, measurement
of testosterone was obtained with electrochemilumines-
cence immunoassays not HPLC tandem mass spectropho-
tometry. Second, the cross-sectional study design doesn’t
allow us to infer temporality. Third, while we adjusted for
factors for which the prevalence differs by race/ethnicity
and that are correlates of obesity, such as physical activity
and smoking status, residual confounding may have influ-
enced the observed associations. Fourth, measurements
of percent body fat and waist circumference are surrogate
markers and may not fully capture the total amount of
body fat or the location of excess body fat. Fifth, in NHANES
III, the percent body fat equation has not been validated in
MA men; we used the equation for NHW men. Finally, we
cannot rule out that these findings may be due to change,
however, adjustment for multiple comparisons was not
conducted due to the exploratory nature of this study.
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Table 2. Association of Overall and Central Body Fatness with Circulating Sex Steroid Hormones and Metabolic Factors by Race/Ethnicity, NHANES III (Phase I), 1988 - 1991
Overall Body Fatness (% Body Fat) Central Body Fatness (WC)
Natural Logarithm Transformed Concentration
Model 1a Model 2b for WC Model 1 Model 2 for PBF
β P Value β P Value β P Value β P Value
Sex-Steroid Hormones
Testosterone, ng/mL
NHW -0.017 < 0.0001 -0.0020 0.49 -0.010 < 0.0001 -0.0090 < 0.0001
NHB -0.017 < 0.0001 -0.0033 0.33 -0.010 < 0.0001 -0.0093 < 0.0001
MA -0.016 < 0.0001 -0.0020 0.47 -0.010 < 0.0001 -0.0089 < 0.0001
P-interaction 0.20 0.06 0.11 0.10
Free Testosterone, ng/mL
NHW -0.006 0.03 0.0002 0.94 -0.003 0.001 -0.0034 0.009
NHB -0.005 0.09 0.0001 0.99 -0.003 0.004 -0.0034 0.008
MA -0.004 0.19 0.0016 0.62 -0.003 0.008 -0.0029 0.03
P-interaction 0.17 0.14 0.36 0.37
Estradiol, pg/mL
NHW 0.003 0.06 0.0031 0.24 0.001 0.17 -0.0001 0.93
NHB 0.007 .0007 0.0075 0.02 0.002 0.003 0.0012 0.29
MA 0.001 0.68 0.0009 0.75 0.001 0.59 -0.0007 0.56
P-interaction 0.047 0.04 0.34 0.34
Free Estradiol, pg/mL
NHW 0.011 < 0.0001 0.0043 0.14 0.005 < 0.0001 0.0037 0.009
NHB 0.016 < 0.0001 0.0099 0.005 0.007 < 0.0001 0.0053 0.0004
MA 0.009 0.0009 0.0030 0.33 0.005 < 0.0001 0.0033 0.03
P-interaction 0.18 0.31 0.85 0.86
SHBG, nmol/L
NHW -0.024 < 0.0001 -0.0056 0.19 -0.013 < 0.0001 -0.0107 < 0.0001
NHB -0.023 < 0.0001 -0.0065 0.11 -0.013 < 0.0001 -0.0110 < 0.0001
MA -0.024 < 0.0001 -0.0079 0.05 -0.013 < 0.0001 -0.0114 < 0.0001
P-interaction 0.84 0.48 0.54 0.54
Metabolic factors
Fasting insulin,µU/mL
NHW 0.0447 < 0.0001 0.0075 0.06 0.0239 < 0.0001 0.0215 < 0.0001
NHB 0.0408 < 0.0001 0.0080 0.04 0.0242 < 0.0001 0.0216 < 0.0001
MA 0.0404 < 0.0001 0.0077 0.05 0.0241 < 0.0001 0.0215 < 0.0001
P-interaction 0.33 0.11 0.02 0.02
C-reactive proteinc
NHW 0.0141 0.0005 0.0083 0.09 0.0060 0.0007 0.0032 0.08
NHB 0.0177 0.0001 0.0126 0.02 0.0075 0.0002 0.0044 0.02
MA 0.0143 0.0003 0.0092 0.04 0.0064 0.0008 0.0034 0.10
P-interaction 0.54 0.45 0.89 0.88
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C-reactive proteind
NHW 0.0044 0.70 0.0059 0.71 0.0008 0.86 -0.0009 0.88
NHB 0.0095 0.43 0.0108 0.49 0.0026 0.60 0.0008 0.91
MA -0.0029 0.81 -0.0017 0.91 -0.0014 0.79 -0.0033 0.63
P-interaction 0.29 0.34 0.28 0.27
Total cholesterol, mg/dL
NHW 0.0063 0.0004 0.0042 0.06 0.0026 0.002 0.0013 0.21
NHB 0.0052 0.008 0.0033 0.15 0.0024 0.008 0.0011 0.33
MA 0.0049 0.008 0.0030 0.15 0.0023 0.01 0.0010 0.39
P-interaction 0.98 0.99 0.72 0.71
LDL cholesterol, mg/dL
NHW 0.0088 0.001 0.0051 0.21 0.0037 0.002 0.0022 0.20
NHB 0.0069 0.03 0.0036 0.39 0.0034 0.01 0.0018 0.32
MA 0.0064 0.02 0.0031 0.39 0.0033 0.01 0.0016 0.38
P-interaction 0.83 0.85 0.74 0.73
HDL cholesterol, mg/dL
NHW -0.0115 < 0.0001 -0.0038 0.19 -0.0056 < 0.0001 -0.0045 0.0001
NHB -0.0067 0.006 0.0001 0.99 -0.0046 0.0001 -0.0034 0.003
MA -0.0107 < 0.0001 -0.0040 0.14 -0.0058 < 0.0001 -0.0046 0.0003
P-interaction 0.72 0.73 0.70 0.70
Leptin, fg/L
NHW 0.0886 < 0.0001 0.0373 < 0.0001 0.0414 < 0.0001 0.0297 < 0.0001
NHB 0.0824 < 0.0001 0.0371 < 0.0001 0.0423 < 0.0001 0.0297 < 0.0001
MA 0.0794 < 0.0001 0.0343 < 0.0001 0.0416 < 0.0001 0.0288 < 0.0001
P-interaction 0.72 0.43 0.74 0.69
IGF-1, ng/mL
NHW -0.0065 0.05 -0.0025 0.55 -0.0031 0.03 -0.0023 0.22
NHB -0.0077 0.02 -0.0041 0.27 -0.0037 0.01 -0.0028 0.15
MA -0.0100 0.002 -0.0065 0.08 -0.0044 0.004 -0.0035 0.08
P-interaction 0.84 0.87 0.99 0.99
IGFBP-3, ng/mL
NHW 0.0037 0.06 0.0032 0.20 0.0013 0.20 0.0004 0.75
NHB 0.0002 0.90 -0.0002 0.93 0.0003 0.73 -0.0006 0.65
MA 0.0001 0.97 -0.0004 0.87 0.0003 0.72 -0.0006 0.65
P-interaction 0.09 0.09 0.23 0.23
Abbreviations: PBF, Percent Body Fat; WC, waist circumference.
aModel 1: regression coefficients (β) adjusted for age, cigarette smoking status, cotinine concentration, alcohol consumption, and physical activity.
bModel 2: Same as Model 1 and additionally adjusted for waist circumference (in analysis of percent body fat) or percent body fat (in analysis of waist circumference).
cC-reactive protein above versus at or below the limit of detection (LOD) of 0.21 mg/dL.
dRestricted to men with C-reactive protein above the LOD of 0.21 mg/dL (N = 256).
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Table 2 (Continue). Association of Overall and Central Body Fatness with Circulating Sex Steroid Hormones and Metabolic Factors by Race/Ethnicity, NHANES III (Phase I),
1988 - 1991
Overall Body Fatness (% Body Fat) Central Body Fatness (WC)
Natural Logarithm Transformed Concentration
Model 1a Model 2b for WC Model 1 Model 2 for PBF
β P Value β P Value β P Value β P Value
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Table 3. Summary of Mutually-Adjusted Associations of Overall and Central Body Fatness with Circulating Concentrations of Sex Steroid Hormones and Metabolic Factors by
Race/Ethnicity, Men NHANES III (Phase I), 1988 - 1991a
Variables NHW NHB MA
Percent Body Fat Waist
Circumference
Percent Body Fat Waist
Circumference
Percent Body Fat Waist
Circumference
Sex-steroid
hormones
Total
testosterone
- ↓b - ↓ - ↓
Free
testosterone
- ↓ - ↓ - ↓
Total estradiol - - ↑c - - -
Free estradiol - ↑ ↑ ↑ - ↑
SHBG - ↓ - ↓ ↓ ↓
Metabolic factors
Fasting
insulin
↑ ↑ ↑ ↑ ↑ ↑
C-reactive
protein (>
limit of
detection of
0.21 mg/dL)
↑ ↑ ↑ ↑ ↑ ↑
Total
cholesterol
↑ - - - - -
LDL
cholesterol
- - - - - -
HDL
cholesterol
- ↓ - ↓ - ↓
Leptin ↑ ↑ ↑ ↑ ↑ ↑
IGF-1 - - - - ↑ ↑
IGFBP-3 - - - - - -
aAssociations for overall body fatness were adjusted for waist circumference and vice versa, and all associations are additionally adjusted for age, cigarette smoking
status, cotinine level, alcohol consumption, and physical activity.
bDenotes a statistically significant inverse association. Arrow without an asterisk denotes a possible association (0.05≤ P≤ 0.10).
cDenotes a statistically significant positive association.
In conclusion, we found that the patterns of asso-
ciation of overall and central body fatness with circu-
lating hormones and metabolic factors were similar by
race/ethnicity in men, with a few notable exceptions that
are important, but cannot be further teased out in this
study including because adipose tissue compartment (i.e.,
visceral and subcutaneous adipose tissue) were not mea-
sured. These findings highlight the importance of the anal-
ysis of body fatness and risk of cancer and other conditions
by race/ethnicity.
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